L'Oréal Valuation

Is OR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OR (€339.85) is trading below our estimate of fair value (€345.14)

Significantly Below Fair Value: OR is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OR?

Key metric: As OR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OR. This is calculated by dividing OR's market cap by their current earnings.
What is OR's PE Ratio?
PE Ratio28.1x
Earnings€6.48b
Market Cap€181.81b

Price to Earnings Ratio vs Peers

How does OR's PE Ratio compare to its peers?

The above table shows the PE ratio for OR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.4x
ITP Interparfums
27.1x10.3%€3.0b
ULVR Unilever
20.5x5.7%UK£113.0b
500696 Hindustan Unilever
53.5x9.6%₹5.5t
HLN Haleon
28.7x10.6%UK£34.6b
OR L'Oréal
28.1x7.5%€181.8b

Price-To-Earnings vs Peers: OR is good value based on its Price-To-Earnings Ratio (28.1x) compared to the peer average (32.4x).


Price to Earnings Ratio vs Industry

How does OR's PE Ratio compare vs other companies in the European Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
OR 28.1xIndustry Avg. 23.8xNo. of Companies4PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OR is expensive based on its Price-To-Earnings Ratio (28.1x) compared to the European Personal Products industry average (23.8x).


Price to Earnings Ratio vs Fair Ratio

What is OR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28.1x
Fair PE Ratio36.2x

Price-To-Earnings vs Fair Ratio: OR is good value based on its Price-To-Earnings Ratio (28.1x) compared to the estimated Fair Price-To-Earnings Ratio (36.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€339.85
€398.60
+17.3%
12.2%€502.00€280.00n/a25
Dec ’25€328.65
€408.35
+24.2%
13.1%€508.00€280.00n/a26
Nov ’25€346.50
€414.96
+19.8%
10.8%€508.00€325.00n/a26
Oct ’25€391.60
€440.19
+12.4%
10.1%€525.00€350.00n/a26
Sep ’25€396.60
€443.68
+11.9%
9.9%€525.00€350.00n/a25
Aug ’25€387.85
€446.64
+15.2%
10.0%€526.00€350.00n/a25
Jul ’25€412.25
€449.08
+8.9%
11.1%€530.00€340.00n/a25
Jun ’25€452.10
€448.04
-0.9%
11.0%€530.00€340.00n/a25
May ’25€439.65
€446.52
+1.6%
11.0%€530.00€340.00n/a25
Apr ’25€438.65
€439.71
+0.2%
11.9%€530.00€320.00n/a24
Mar ’25€441.95
€438.44
-0.8%
11.8%€530.00€320.00n/a25
Feb ’25€449.35
€428.52
-4.6%
11.1%€525.00€320.00n/a25
Jan ’25€450.65
€424.04
-5.9%
10.7%€505.00€320.00n/a25
Dec ’24€436.15
€420.84
-3.5%
9.9%€500.00€320.00€328.6525
Nov ’24€397.00
€420.64
+6.0%
10.2%€500.00€320.00€346.5025
Oct ’24€393.20
€422.16
+7.4%
10.3%€500.00€320.00€391.6025
Sep ’24€405.20
€424.84
+4.8%
10.0%€500.00€320.00€396.6025
Aug ’24€416.05
€423.44
+1.8%
10.2%€500.00€320.00€387.8525
Jul ’24€427.10
€417.96
-2.1%
10.1%€495.00€320.00€412.2525
Jun ’24€400.15
€416.40
+4.1%
10.4%€495.00€320.00€452.1025
May ’24€432.75
€412.00
-4.8%
11.5%€495.00€296.00€439.6525
Apr ’24€411.25
€380.67
-7.4%
10.3%€450.00€290.00€438.6524
Mar ’24€372.00
€379.50
+2.0%
10.6%€450.00€290.00€441.9524
Feb ’24€372.40
€369.67
-0.7%
9.9%€440.00€290.00€449.3524
Jan ’24€333.60
€361.88
+8.5%
10.1%€440.00€280.00€450.6524
Dec ’23€358.40
€365.04
+1.9%
10.1%€440.00€280.00€436.1524

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 10:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

L'Oréal S.A. is covered by 76 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Armelle MoulinAlphaValue
John StaszakArgus Research Company
null nullBanco de Sabadell. S.A.